PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.\', \'Department of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.\', \'Shenzhen Center for Disease Control and Prevention, Shenzhen, China.\', \'School of Public Health (Shenzhen), Sun Yet-Sen University, Shenzhen, China.\', \'Key Laboratory of Tropical Disease Control, Ministry of Education, Sun Yat-sen University, Guangzhou, China.\', \'State Key Laboratory of Digestive Diseases, Li Ka Shing Institute of Health Sciences, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2021.785599
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 35058926
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Hypozincemia in COVID-19 Patients Correlates With Stronger Antibody Response.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all